See more : ChinHung International, Inc. (002780.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Australis Capital Inc. (AUSAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Australis Capital Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Diamond Bancshares, Inc. (DMNB) Income Statement Analysis – Financial Results
- Rhino Resource Partners LP (RHNO) Income Statement Analysis – Financial Results
- Guangdong Hongda Holdings Group Co., Ltd. (002683.SZ) Income Statement Analysis – Financial Results
- Worldwide Holdings Corp. (WWDH) Income Statement Analysis – Financial Results
- Akebono Brake Industry Co., Ltd. (AKBIF) Income Statement Analysis – Financial Results
Australis Capital Inc. (AUSAF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.ausa-corp.com
About Australis Capital Inc.
Australis Capital Inc. operates as a cannabis company. It undertakes cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, the United Arab Emirates, Southeast Asia, and Australia, as well as other jurisdictions. The company is based in Las Vegas, Nevada.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 7.57M | 570.59K | 221.48K | 129.76K | 0.00 | 0.00 |
| Cost of Revenue | 3.61M | 1.21M | 221.26K | 2.34K | 0.00 | 0.00 |
| Gross Profit | 3.97M | -635.54K | 222.00 | 127.42K | 0.00 | 0.00 |
| Gross Profit Ratio | 52.39% | -111.38% | 0.10% | 98.20% | 0.00% | 0.00% |
| Research & Development | 0.00 | 119.90 | 19.03 | -28.26 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 13.24M | 13.65M | 4.00M | 1.04K | 5.34K |
| Selling & Marketing | 0.00 | 393.20 | 369.35K | 432.94 | 0.00 | 0.00 |
| SG&A | 23.55M | 13.24M | 14.02M | 4.00M | 1.04K | 5.34K |
| Other Expenses | 1.70M | -8.84M | 1.73M | 1.09M | 1.72K | -33.88K |
| Operating Expenses | 25.25M | 8.84M | 14.62M | 4.01M | 1.04K | 5.50K |
| Cost & Expenses | 28.86M | 10.05M | 14.62M | 4.01M | 1.04K | 5.50K |
| Interest Income | 0.00 | 106.77K | 936.76K | 279.71K | 47.16K | 45.02 |
| Interest Expense | 0.00 | 125.22K | 196.56K | 455.69K | 90.54K | 0.00 |
| Depreciation & Amortization | 1.36M | 10.05M | 13.01M | 588.19K | 71.04K | 68.80K |
| EBITDA | -14.13M | -8.87M | -12.25M | -3.01M | 47.85K | -45.18K |
| EBITDA Ratio | -186.60% | -1,553.86% | -5,532.55% | -2,317.99% | 0.00% | 0.00% |
| Operating Income | -15.49M | -9.48M | -14.40M | -4.29M | -1.04K | -5.34K |
| Operating Income Ratio | -204.57% | -1,661.15% | -6,500.66% | -3,309.51% | 0.00% | 0.00% |
| Total Other Income/Expenses | -25.40M | -5.36M | -8.94M | 1.55M | -41.66K | 1.33K |
| Income Before Tax | -40.89M | -19.39M | -23.34M | -4.17M | -42.70K | -4.00K |
| Income Before Tax Ratio | -540.02% | -3,398.90% | -10,539.07% | -3,214.58% | 0.00% | 0.00% |
| Income Tax Expense | 247.44K | -62.18K | 802.74K | 1.04M | 43.38K | -4.00K |
| Net Income | -40.03M | -20.10M | -23.34M | -4.17M | -42.70K | -37.88K |
| Net Income Ratio | -528.67% | -3,522.40% | -10,539.07% | -3,214.58% | 0.00% | 0.00% |
| EPS | -0.16 | -0.11 | -0.14 | -0.04 | 0.00 | 0.00 |
| EPS Diluted | -0.16 | -0.11 | -0.14 | -0.04 | 0.00 | -37.88K |
| Weighted Avg Shares Out | 247.49M | 177.12M | 162.36M | 94.37M | 119.99M | 0.00 |
| Weighted Avg Shares Out (Dil) | 247.49M | 177.12M | 162.36M | 94.37M | 119.99M | 0.00 |
Australis Files Q4 and Full Year Fiscal 2021 Results
COMPANY TO FILE Q1 FISCAL 2022 RESULTS FRIDAY AUGUST 27, 2021 CONFERENCE CALL ON MONDAY, AUGUST 30, 2021 AT 11:00AM ET TRADING EXPECTED TO RESUME WITHIN 24-48 HOURS LAS VEGAS, Aug. 26, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA)...
AUSA Anticipating Cease Trade to be Lifted Shortly
Slight Delay in Audit Finalization, Anticipated to be Completed Shortly LAS VEGAS, Aug. 6, 2021 /PRNewswire/ - Australis Capital Inc., operating as Audacious (CSE: AUSA) (OTC: AUSAF) ("AUSA", "Audacious", or the "Company"), today commented on the cease trade order of...
Audacious inks deal to acquire California CBD beverage and edibles brand LOOS
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF), which is doing business as Audacious, has announced that it is acquiring California cannabinoid beverages and edibles firm Gary Maverick Inc, which operates as LOOS, in an all-stock deal. It is Las Vegas-based Audacious's first...
Audacious Acquires LOOS, a California Shot Beverage and Edibles Company
Back-End Loaded Transaction Expands Audacious Product Portfolio into THC and CBD Infused Beverage Category Loos Management Team Has Highly Successful Track Record in California Edibles Market Rapid Onset Shots Product Line with Rapidly Growing Pre-Sales in California Market LAS VEGAS,...
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
NEW YORK, July 1, 2021 /PRNewswire/ -- Virtual Investor Conferences® and KCSA Strategic Communications today announced that the presentations from the June 29 th & 30th Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com. REGISTER OR...
Australis Capital to change name to Audacious Brand and finalizes land purchase in Nevada
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) said going forward, it will operate under the name Audacious Brand and will consolidate its product line under the Audacious banner. The Nevada-based company will focus on its US adult market operations and will feature...
Australis Corporation Changes Name to Audacious Brands - Provides Corporate Update
Audacious Operationalizing Missouri – Completes Nevada Land Purchase - ALPS Continues to Lead the Way in ESG Projects LAS VEGAS, June 22, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") today announced that the...
Australis Capital touts new study that shows medical cannabis can reduce opioid use, the progress of its subsidiaries and more in corporate update
Australis Capital Inc (CSE:AUSA) (OTC:AUSAF) issued a corporate update, highlighting a groundbreaking University of Alberta study medical cannabis study, a new chairman, Green Therapeutics' work in Nevada, among other news. The objective of the study was to assess the effect of...
Australis Provides Corporate Update
LAS VEGAS, May 26, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today provided the following corporate update: Ground-Breaking University of Alberta Study, Co-Led by AUSA CSO Dr. Jason Dyck, Confirms Opioid Sparing Effects of Medical Cannabis. Australis Chief...
Australis Capital unveils new chief business development officer
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) said it has appointed Leah S Bailey as its chief business development officer to drive commercial initiatives and provide leadership to the company's corporate development team. The cannabis group said with Bailey's appointment, it is...
Source: https://incomestatements.info
Category: Stock Reports